Concepedia

Ruth Salazar

RS

Statistics

Publications

5

Citations

1.8K

H-Index

5

Active since

2017

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Moffitt Cancer Center

Oregon Health & Science University

MedStar Washington Hospital Center

University of Michigan

Ruth Salazar is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

2017–2022

5

Publications

5

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack et al. · The Lancet Oncology · 2017 · 1.4K citations · Full text

Medicine, Oncology, Pharmacology +13

Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab

Emily Z. Keung, Melissa Burgess, Ruth Salazar et al. · Clinical Cancer Research · 2020 · 211 citations · Full text

Medicine, Immunology, Oncology +17

Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial

Neeta Somaiah, Anthony P. Conley, Edwin R. Parra et al. · The Lancet Oncology · 2022 · 157 citations

Medicine, Oncology, Pharmacology +16

CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma

Pedro Rocha, Ruth Salazar, Jiexin Zhang et al. · Cancer Immunology Immunotherapy · 2021 · 29 citations · Full text

Medicine, Oncology, Pathology +17

The immune landscape of undifferentiated pleomorphic sarcoma

Rossana Lazcano, Carmélia Maria Noia Barreto, Ruth Salazar et al. · Frontiers in Oncology · 2022 · 26 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 5